Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.

Reset
4290 results found

Intratumor MAPK and PI3K signaling pathway heterogeneity in glioblastoma tissue correlates with CREB signaling and distinct target gene signatures

Daniel, PM; Filiz, G; Tymms, MJ; Ramsay, RG; Kaye, AH; Stylli, SS; Mantamadiotis, T

(2018), Exp. Mol. Pathol., 23-31

DOI: 10.1016/j.yexmp.2018.05.009

Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trial

Field, KM; Fitt, G; Rosenthal, MA; Simes, J; Nowak, AK; Barnes, EH; Sawkins, K; Goh, C; Moffat, BA; Salinas, S; Cher, L; Wheeler, H; Hovey, EJ; Phal, PM

(2018), Asia-Pac. J. Clin. Oncol., e359-e365

DOI: 10.1111/ajco.12806

Non-smoking, non-drinking elderly females, a 5 year follow-up of a clinically distinct cohort of oral squamous cell carcinoma patients

DeAngelis, A; Breik, O; Koo, K; Iseli, T; Nastri, A; Fua, T; Rischin, D; McCullough, M; Wiesenfeld, D

(2018), Oral Oncol., 113-120

DOI: 10.1016/j.oraloncology.2018.09.004

Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response

Sud, S; O'Callaghan, C; Jonker, C; Karapetis, C; Price, T; Tebbutt, N; Shapiro, J; Van Hazel, G; Pavlakis, N; Gibbs, P; Jeffrey, M; Siu, L; Gill, S; Wong, R; Jonker, D; Tu, D; Goodwin, R

(2018), Curr. Oncol., E516-E526

DOI: 10.3747/co.25.4069

Nivolumab for the treatment of colorectal cancer

Smith, KM; Desai, J

(2018), Expert Rev. Anticancer Ther, 611-618

DOI: 10.1080/14737140.2018.1480942

MACROD2 Haploinsufficiency Impairs Catalytic Activity of PARP1 and Promotes Chromosome Instability and Growth of Intestinal Tumors

Sakthianandeswaren, A; Parsons, MJ; Mouradov, D; MacKinnon, RN; Catimel, B; Liu, S; Palmieri, M; Love, C; Jorissen, RN; Li, S; Whitehead, L; Putoczki, TL; Preaudet, A; Tsui, C; Nowell, CJ; Ward, RL; Hawkins, NJ; Desai, J; Gibbs, P; Ernst, M; Street, I; Buchert, M; Sieber, OM

(2018), Cancer Discov., 988-1005

DOI: 10.1158/2159-8290.CD-17-0909

A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers

Roohullah, A; Cooper, A; Lomax, AJ; Aung, J; Barge, A; Chow, L; McHale, M; Desai, J; Whittle, JR; Tran, B; de Souza, P; Horvath, LG

(2018), Invest. New Drugs, 886-894

DOI: 10.1007/s10637-018-0588-7

Symptoms of Posttraumatic Stress Disorder and Associated Risk Factors in Patients With Lung Cancer: A Longitudinal Observational Study

Ni, J; Feng, J; Denehy, L; Wu, Y; Xu, LQ; Granger, CL

(2018), Integr. Cancer Ther., 1195-1203

DOI: 10.1177/1534735418807970

Physical Activity Behavior After a Diagnosis of Lung Cancer Differs Between Countries: An Observational Cohort Study

Ni, J; Denehy, L; Feng, J; Xu, LQ; Wu, Y; Granger, CL

(2018), Integr. Cancer Ther., 493-502

DOI: 10.1177/1534735417699513

Neutrophils, G-CSF and their contribution to breast cancer metastasis

Mouchemore, KA; Anderson, RL; Hamilton, JA

(2018), FEBS J., 665-679

DOI: 10.1111/febs.14206

Editorial on Erectile function and oncologic outcomes following open retropubic and robot-assisted radical prostatectomy: results from the LAParoscopic Prostatectomy Robot Open Trial

Moran, D; Zagar, H

(2018), Transl. Androl. Urol., S118-S119

DOI: 10.21037/tau.2017.12.04

Mechanistic Insights of an Immunological Adverse Event Induced by an Anti-KIT Antibody Drug Conjugate and Mitigation Strategies

L'Italien, L; Orozco, O; Abrams, T; Cantagallo, L; Connor, A; Desai, J; Ebersbach, H; Gelderblom, H; Hoffmaster, K; Lees, E; Maacke, H; Schleyer, S; Skegro, D; Lee-Hoeflich, ST

(2018), Clin. Cancer Res., 3465-3474

DOI: 10.1158/1078-0432.CCR-17-3786

Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer

Lichtenstein, M

(2018), J. Clin. Oncol.

DOI: 10.1200/JCO.2018.78.5675

Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia

Lew, JB; St John, DJB; Macrae, FA; Emery, JD; Ee, HC; Jenkins, MA; He, E; Grogan, P; Caruana, M; Greuter, MJE; Coupe, VMH; Canfell, K

(2018), Cancer Epidemiol. Biomarkers Prev., 1450-1461

DOI: 10.1158/1055-9965.EPI-18-0128

Precision oncology using a clinician-directed, tailored approach to molecular profiling

Lam, M; Tran, B; Beck, S; Tie, J; Herath, D; Whittle, J; Kwan, EM; Fox, SB; Fellowes, A; Ananda, S; Lipton, L; Gibbs, P; Rosenthal, MA; Desai, J

(2018), Asia-Pac. J. Clin. Oncol., 84-90

DOI: 10.1111/ajco.12787

Impact of Emergent Circulating Tumor DNA RAS Mutation in Panitumumab-Treated Chemoresistant Metastatic Colorectal Cancer

Kim, TW; Peeters, M; Thomas, A; Gibbs, P; Hool, K; Zhang, JQ; Ang, AL; Bach, BA; Price, T

(2018), Clin. Cancer Res., 5602-5609

DOI: 10.1158/1078-0432.CCR-17-3377

Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer The BOLERO-6 Randomized Clinical Trial

Jerusalem, G; de Boer, RH; Hurvitz, S; Yardley, DA; Kovalenko, E; Ejlertsen, B; Blau, S; Ozguroglu, M; Landherr, L; Ewertz, M; Taran, T; Fan, J; Noel-Baron, F; Louveau, AL; Burris, H

(2018), JAMA Oncol., 1367-1374

DOI: 10.1001/jamaoncol.2018.2262

Re-inventing the randomized controlled trial in medical oncology: The registry-based trial

Foroughi, S; Wong, HL; Gately, L; Lee, M; Simons, K; Tie, J; Burgess, AW; Gibbs, P

(2018), Asia-Pac. J. Clin. Oncol., 365-373

DOI: 10.1111/ajco.12992

Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series

Domingo, E; Camps, C; Kaisaki, PJ; Parsons, MJ; Mouradov, D; Pentony, MM; Makino, S; Palmieri, M; Ward, RL; Hawkins, NJ; Gibbs, P; Askautrud, H; Oukrif, D; Wang, HT; Wood, J; Tomlinson, E; Bark, Y; Kaur, K; Johnstone, EC; Palles, C; Church, DN; Novelli, M; Danielsen, HE; Sherlock, J; Kerr, D; Kerr, R; Sieber, O; Taylor, JC; Tomlinson, I

(2018), Lancet Gastroenterol. Hepatol., 635-643

DOI: 10.1016/S2468-1253(18)30117-1

Incidence of pulmonary embolism in patients with newly diagnosed colorectal cancer

Daniel, ES; Dean, AE; Lim, M; Master, M; Gibbs, P; Faragher, I

(2018), ANZ J. Surg., E228-E231

DOI: 10.1111/ans.13789

A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors

Carducci, M; Shaheen, M; Markman, B; Hurvitz, S; Mahadevan, D; Kotasek, D; Goodman, OB; Rasmussen, E; Chow, V; Juan, G; Friberg, GR; Gamelin, E; Vogl, FD; Desai, J

(2018), Invest. New Drugs, 1060-1071

DOI: 10.1007/s10637-018-0625-6

Down-regulation of a pro-apoptotic pathway regulated by PCAF/ADA3 in early stage gastric cancer

Brasacchio, D; Busuttil, RA; Noori, T; Johnstone, RW; Boussioutas, A; Trapani, JA

(2018), Cell Death Dis.

DOI: 10.1038/s41419-018-0470-8

A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours

Aung, KL; El-Khoueiry, AB; Gelmon, K; Tran, B; Bajaj, G; He, B; Chen, T; Zhu, LL; Poojary, S; Basak, S; Qi, ZH; Spreafico, A; Fischer, BS; Desai, J

(2018), Invest. New Drugs, 1026-1036

DOI: 10.1007/s10637-018-0597-6

How accurate are medical oncologists' impressions of management of metastatic colorectal cancer in Australia?

Au, L; Turner, N; Wong, HL; Field, K; Lee, B; Boadle, D; Cooray, P; Karikios, D; Kosmider, S; Lipton, L; Nott, L; Parente, P; Tie, J; Tran, B; Wong, R; Yip, D; Shapiro, J; Gibbs, P

(2018), Asia-Pac. J. Clin. Oncol., E167-E174

DOI: 10.1111/ajco.12671

Mortality in a cohort of remote-living Aboriginal Australians and associated factors

Hyde, Z; Smith, K; Flicker, L; Atkinson, D; Almeida, OP; Lautenschlager, NT; Dwyer, A; LoGiudice, D

(2018), PLoS One

DOI: 10.1371/journal.pone.0195030

It's turned our world upside down': Support needs of parents of critically injured children during Emergency Department admission - A qualitative inquiry

Wiseman, T; Curtis, K; Young, A; Van, C; Foster, K

(2018), Australas. Emerg. Care, 137-142

DOI: 10.1016/j.auec.2018.09.002

Recovery After Psychosis: Qualitative Study of Service User Experiences of Lived Experience Videos on a Recovery-Oriented Website

Williams, A; Fossey, E; Farhall, J; Foley, F; Thomas, N

(2018), JMIR Ment. Health

DOI: 10.2196/mental.9934

Going Online Together: The Potential for Mental Health Workers to Integrate Recovery Oriented E-Mental Health Resources Into Their Practice

Williams, A; Fossey, E; Farhall, J; Foley, F; Thomas, N

(2018), Psychiatry-Interpers. Biol. Process., 116-129

DOI: 10.1080/00332747.2018.1492852

Deterioration of visuospatial associative memory following a first psychotic episode: a long-term follow-up study

Wannan, CMJ; Bartholomeusz, CF; Cropley, VL; Van Rheenen, TE; Panayiotou, A; Brewer, WJ; Proffitt, TM; Henry, L; Harris, MG; Velakoulis, D; McGorry, P; Pantelis, C; Wood, SJ

(2018), Psychol. Med., 132-141

DOI: 10.1017/S003329171700157X

Large-Scale Network Topology Reveals Heterogeneity in Individuals With at Risk Mental State for Psychosis: Findings From the Longitudinal Youth-at-Risk Study

Wang, CH; Lee, J; Ho, NF; Lim, JKW; Poh, JS; Rekhi, G; Krishnan, R; Keefe, RSE; Adcock, RA; Wood, SJ; Fornito, A; Chee, MWL; Zhou, J

(2018), Cereb. Cortex, 4234-4243

DOI: 10.1093/cercor/bhx278